https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: current status and future perspectives https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38300 AntagomiRs are synthetic antagonists of miRNA, which prevent the target mRNA from suppression. Therapeutic approaches that modulate miRNAs have immense potential in the treatment of chronic respiratory disorders. However, the successful delivery of miRNAs/antagomiRs to the lungs remains a major challenge in clinical applications. A range of materials, namely, polymer nanoparticles, lipid nanocapsules and inorganic nanoparticles, has shown promising results for intracellular delivery of miRNA in chronic respiratory disorders. This review discusses the current understanding of miRNA biology, the biological roles of antagomiRs in chronic respiratory disease and the recent advances in the therapeutic utilization of antagomiRs as disease biomarkers. Furthermore our review provides a common platform to debate on the nature of antagomiRs and also addresses the viewpoint on the new generation of delivery systems that target antagomiRs in respiratory diseases.]]> Wed 27 Oct 2021 10:02:42 AEDT ]]> Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:38204 Wed 18 Aug 2021 09:53:13 AEST ]]> Treatment of chronic airway diseases using nutraceuticals: mechanistic insight https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46280 Tue 15 Nov 2022 08:30:52 AEDT ]]> Plants derived therapeutic strategies targeting chronic respiratory diseases: chemical and immunological perspective https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47212 Fri 16 Dec 2022 10:09:29 AEDT ]]>